Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/E8DE783CB158418A2A1B0E90F0C1FD5E58FA0BD4D444E60C0741747ECF356DBA7B6D09CA391FFA3D6C41A6E8C9D2819Dhttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/E8DE783CB158418A2A1B0E90F0C1FD5E58FA0BD4D444E60C0741747ECF356DBA7B6D09CA391FFA3D6C41A6E8C9D2819Dhttp://www.w3.org/2000/01/rdf-schema#comment"NCAPD2 and NCAPD3 expression levels have been confirmed to be significantly up-regulated in the intestinal mucosa of patients with active ulcerative colitis. In vitro the data suggested that silencing NACPD2 and NACPD3 could depress the expression of IL-1beta IL-6 and TNF-alpha. Further knockdown of NACPD2 and NACPD3 could remarkably suppress IKK nucleation and NF-kappaB volume."xsd:string
http://purl.uniprot.org/uniprot/#_0D4D02E1CF6606ADFC3512DE9E0B63517B60A2710F4C792B3679B09964C50F2AA84C635CC699CCF021FE23F7767C9479http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/E8DE783CB158418A2A1B0E90F0C1FD5E58FA0BD4D444E60C0741747ECF356DBA7B6D09CA391FFA3D6C41A6E8C9D2819D
http://purl.uniprot.org/uniprot/Q96FA6http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/E8DE783CB158418A2A1B0E90F0C1FD5E58FA0BD4D444E60C0741747ECF356DBA7B6D09CA391FFA3D6C41A6E8C9D2819D
http://purl.uniprot.org/uniprot/#_Q96FA6-mappedCitation-31885422http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/E8DE783CB158418A2A1B0E90F0C1FD5E58FA0BD4D444E60C0741747ECF356DBA7B6D09CA391FFA3D6C41A6E8C9D2819D